Beta Bionics, Inc.
Beta Bionics, Inc. (BBNX) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · BBNX · as of Jun 8, 2026
Activity summary
Buy transactions
0
P-Purchase only
Sell transactions
50
12 Months
Buy/Sell ratio
0.00
Buy/Sell (by trades)
Overall sentiment
Beta Bionics, Inc. insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 8, 2026
BBNX insider buying and selling by quarter
BBNX insider selling · BBNX insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 8, 2026
Active insiders
Most active in past 12 months · BBNX ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
BBNX executive sell shares · BBNX board member insider trading · BBNX insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Jun 4, 2026 | Hopman Mark Chief Commercial Officer | Sale | 275 | $3K | Form 4 |
| Jun 4, 2026 | Jones Christy Director | Sale | 2,811 | $39K | Form 4 |
| Jun 2, 2026 | Mensinger Mike Chief Product Officer | Sale | 4,378 | $55K | Form 4 |
| Jun 2, 2026 | Hopman Mark Chief Commercial Officer | Sale | 5,329 | $67K | Form 4 |
| Jun 2, 2026 | Russell Steven Jon Chief Medical Officer | Sale | 4,222 | $53K | Form 4 |
| Jun 2, 2026 | Feider Stephen CFO | Sale | 6,676 | $84K | Form 4 |
| Jun 2, 2026 | Saint Sean President & CEO · Director | Sale | 16,872 | $213K | Form 4 |
| May 21, 2026 | MICHEL GERARD J Director | Award | 16,965 | — | Form 4 |
| May 21, 2026 | Jones Christy Director | Award | 16,965 | — | Form 4 |
| May 21, 2026 | Jones Christy Director | Sale | 1,998 | $20K | Form 4 |
| May 21, 2026 | Palasis Maria Director | Award | 16,965 | — | Form 4 |
| May 21, 2026 | Dearen Danny L. Director | Award | 16,965 | — | Form 4 |
| May 21, 2026 | CARNEY SEAN Director | Award | 16,965 | — | Form 4 |
| May 21, 2026 | Lezack Adam Director | Award | 16,965 | — | Form 4 |
| May 21, 2026 | Lezack Adam Director | Sale | 1,000 | $10K | Form 4 |
| Dec 2, 2025 | Hopman Mark Chief Commercial Officer | Sale | 856 | $25K | Form 4 |
| Dec 4, 2025 | Hopman Mark Chief Commercial Officer | Sale | 2,061 | $63K | Form 4 |
| Dec 2, 2025 | Russell Steven Jon Chief Medical Officer | Sale | 1,025 | $30K | Form 4 |
| Mar 4, 2026 | Hopman Mark Chief Commercial Officer | Sale | 353 | $4K | Form 4 |
| Feb 27, 2026 | Hopman Mark Chief Commercial Officer | Award | 109,105 | — | Form 4 |
| Mar 2, 2026 | Hopman Mark Chief Commercial Officer | Sale | 834 | $10K | Form 4 |
| Feb 27, 2026 | Russell Steven Jon Chief Medical Officer | Award | 109,105 | — | Form 4 |
| Mar 2, 2026 | Russell Steven Jon Chief Medical Officer | Sale | 1,026 | $13K | Form 4 |
| Feb 27, 2026 | Mensinger Mike Chief Product Officer | Award | 109,105 | — | Form 4 |
| Mar 2, 2026 | Mensinger Mike Chief Product Officer | Sale | 1,064 | $13K | Form 4 |
Mensinger Mike
Chief Product Officer
Date
Jun 2
Shares
4,378
Price
$12.61
Value
$55K
Hopman Mark
Chief Commercial Officer
Date
Jun 2
Shares
5,329
Price
$12.61
Value
$67K
Russell Steven Jon
Chief Medical Officer
Date
Jun 2
Shares
4,222
Price
$12.61
Value
$53K
Saint Sean
President & CEO · Director
Date
Jun 2
Shares
16,872
Price
$12.61
Value
$213K
Hopman Mark
Chief Commercial Officer
Date
Dec 4
Shares
2,061
Price
$30.66
Value
$63K
Russell Steven Jon
Chief Medical Officer
Date
Dec 2
Shares
1,025
Price
$29.34
Value
$30K
Russell Steven Jon
Chief Medical Officer
Date
Feb 27
Shares
109,105
Price
—
Value
—
Russell Steven Jon
Chief Medical Officer
Date
Mar 2
Shares
1,026
Price
$12.36
Value
$13K
Mensinger Mike
Chief Product Officer
Date
Mar 2
Shares
1,064
Price
$12.36
Value
$13K
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About BBNX insider trading
BBNX insider trades
Beta Bionics, Inc. (BBNX) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Feider Stephen (CFO), Hopman Mark (Chief Commercial Officer), Mensinger Mike (Chief Product Officer). Over the past 12 months, 5 insiders have filed transactions with the SEC. BBNX insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Beta Bionics, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
BBNX insider trading · 5 questionsThe insiders of Beta Bionics, Inc. (BBNX) include executives and directors such as Feider Stephen (CFO), Hopman Mark (Chief Commercial Officer), Mensinger Mike (Chief Product Officer), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026